A retrospective French cohort study in 311 patients with IDH-mutant anaplastic astrocytoma estimated that, following radiotherapy, grade 3/4 toxicities were statistically significantly more frequent with PCV than TMZ (46.7 versus 7.8%, p-value<0.0001) (164). Here, IDH1 is linked to anaplastic astrocytoma.